China · Delayed Price · Currency is CNY Sage Therapeutics Statistics
Total Valuation
SHA:603530 has a market cap or net worth of CNY 12.37 billion. The enterprise value is 12.17 billion.
| Market Cap | 12.37B |
| Enterprise Value | 12.17B |
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | Jun 4, 2025 |
Share Statistics
SHA:603530 has 428.70 million shares outstanding. The number of shares has increased by 3.72% in one year.
| Current Share Class | 428.70M |
| Shares Outstanding | 428.70M |
| Shares Change (YoY) | +3.72% |
| Shares Change (QoQ) | -1.86% |
| Owned by Insiders (%) | 80.36% |
| Owned by Institutions (%) | 6.72% |
| Float | 79.72M |
Valuation Ratios
The trailing PE ratio is 38.99 and the forward PE ratio is 29.74. SHA:603530's PEG ratio is 0.80.
| PE Ratio | 38.99 |
| Forward PE | 29.74 |
| PS Ratio | 8.84 |
| PB Ratio | 6.69 |
| P/TBV Ratio | 7.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 196.04 |
| PEG Ratio | 0.80 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 28.38, with an EV/FCF ratio of -152.99.
| EV / Earnings | 38.61 |
| EV / Sales | 8.70 |
| EV / EBITDA | 28.38 |
| EV / EBIT | 34.85 |
| EV / FCF | -152.99 |
Financial Position
The company has a current ratio of 2.75, with a Debt / Equity ratio of 0.13.
| Current Ratio | 2.75 |
| Quick Ratio | 1.88 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.55 |
| Debt / FCF | -2.97 |
| Interest Coverage | 164.21 |
Financial Efficiency
Return on equity (ROE) is 18.01% and return on invested capital (ROIC) is 11.68%.
| Return on Equity (ROE) | 18.01% |
| Return on Assets (ROA) | 9.83% |
| Return on Invested Capital (ROIC) | 11.68% |
| Return on Capital Employed (ROCE) | 18.32% |
| Revenue Per Employee | 766,138 |
| Profits Per Employee | 172,619 |
| Employee Count | 1,826 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 2.29 |
Taxes
In the past 12 months, SHA:603530 has paid 55.53 million in taxes.
| Income Tax | 55.53M |
| Effective Tax Rate | 14.98% |
Stock Price Statistics
The stock price has increased by +20.74% in the last 52 weeks. The beta is 0.70, so SHA:603530's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | +20.74% |
| 50-Day Moving Average | 26.21 |
| 200-Day Moving Average | 25.35 |
| Relative Strength Index (RSI) | 64.84 |
| Average Volume (20 Days) | 3,861,921 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603530 had revenue of CNY 1.40 billion and earned 315.20 million in profits. Earnings per share was 0.74.
| Revenue | 1.40B |
| Gross Profit | 600.75M |
| Operating Income | 349.16M |
| Pretax Income | 370.73M |
| Net Income | 315.20M |
| EBITDA | 428.76M |
| EBIT | 349.16M |
| Earnings Per Share (EPS) | 0.74 |
Balance Sheet
The company has 434.29 million in cash and 236.03 million in debt, giving a net cash position of 198.26 million or 0.46 per share.
| Cash & Cash Equivalents | 434.29M |
| Total Debt | 236.03M |
| Net Cash | 198.26M |
| Net Cash Per Share | 0.46 |
| Equity (Book Value) | 1.85B |
| Book Value Per Share | 4.31 |
| Working Capital | 1.03B |
Cash Flow
In the last 12 months, operating cash flow was 63.09 million and capital expenditures -142.63 million, giving a free cash flow of -79.55 million.
| Operating Cash Flow | 63.09M |
| Capital Expenditures | -142.63M |
| Free Cash Flow | -79.55M |
| FCF Per Share | -0.19 |
Margins
Gross margin is 42.94%, with operating and profit margins of 24.96% and 22.53%.
| Gross Margin | 42.94% |
| Operating Margin | 24.96% |
| Pretax Margin | 26.50% |
| Profit Margin | 22.53% |
| EBITDA Margin | 30.65% |
| EBIT Margin | 24.96% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.46, which amounts to a dividend yield of 1.62%.
| Dividend Per Share | 0.46 |
| Dividend Yield | 1.62% |
| Dividend Growth (YoY) | 76.92% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 35.26% |
| Buyback Yield | -3.72% |
| Shareholder Yield | -2.10% |
| Earnings Yield | 2.55% |
| FCF Yield | -0.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHA:603530 has an Altman Z-Score of 11.57 and a Piotroski F-Score of 4.
| Altman Z-Score | 11.57 |
| Piotroski F-Score | 4 |